Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891317 · ClinicalTrials.gov registry record
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02891317 is a clinical trial that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2 participants.
The verdict
NCT02891317 was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to assess how surgical interventions in glaucoma affect 24-hour intraocular pressure, 24-hour ocular perfusion pressure, optic nerve blood flow, and retinal oxygen saturation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2017-06-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02891317
The ClinicalTrials.gov registry entry for NCT02891317 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02891317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02891317 about?
NCT02891317 is a clinical study titled "Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma". The purpose of this study is to assess how surgical interventions in glaucoma affect 24-hour intraocular pressure, 24-hour ocular perfusion pressure, optic nerve blood flow, and retinal oxygen saturation.
What is the current status of trial NCT02891317?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2017-05-08. Estimated completion is 2017-06-12.
Who is sponsoring clinical trial NCT02891317?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.